Clinical Trial Update: Feasibility Study of SBRT Plus Chemotherapy for Non-Small Cell Lung Carcinoma [EARLY_Phase 1]

View source ↗

Summary

This EARLY_PHASE1 feasibility trial evaluating SBRT plus chemotherapy for Stage I–II non-small cell lung cancer was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Case Comprehensive Cancer Center | Conditions: Stage I Non-Small Cell Lung Cancer, Stage II Non-Small Cell Lung Cancer | EARLY_Phase 1 | Status: TERMINATED